Recent Updates
Recently added Catalysts
OKYO Neutral Sentiment Score: 50/100

OKYO PHARMA LIMITED ("OKYO" or "the Company") Interim Results - availability The OKYO Pharma Interim Report for the half-year ended 30 September 2022 (the "Interim Report") is available on the Company's website and can b

Key Takeaway: OKYO Pharma Limited has made its Interim Report for the half-year ending September 30, 2022 available on its website and through the National Storage Mechanism. The report includes details regarding the company’s interim results, providing investors with transparency about its financial performance. Stakeholders can access the document online for further insights into the company's operations during this period.

Market Sentiment Analysis

Full Press Release Details

Results - availability
OKYO Pharma Interim Report for the half-year ended 30 September 2022 (the "Interim Report") is available on the Company's
copy of the above document was submitted to the National Storage Mechanism and is available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
LifeSci Advisors (Investor Relations) Irina Koffler
ikoffler@lifesciadvisors.com
+1-917-734-7387

Frequently Asked Questions

Where can I find the OKYO Pharma Interim Report?

The Interim Report is available on OKYO Pharma's website.

What date does the Interim Report cover?

It covers the half-year ended 30 September 2022.

Where else can I access the Interim Report?

A copy is submitted to the National Storage Mechanism for inspection.

Who can I contact for investor relations inquiries?

Contact Irina Koffler at LifeSci Advisors for investor relations.

What is Irina Koffler's contact email?

You can email Irina Koffler at ikoffler@lifesciadvisors.com.

Last updated: Jan 3, 2023